Merck KGaA (OTCPK:MKGAF)
$ 161 0.26 (0.16%) Market Cap: 70.80 Bil Enterprise Value: 79.36 Bil PE Ratio: 24.98 PB Ratio: 2.30 GF Score: 92/100

Full Year 2020 Merck KGaA Earnings Call Transcript

Mar 04, 2021 / 01:00PM GMT
Release Date Price: $160 (+0.90%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst conference call on Fourth Quarter 2020. (Operator Instructions) May I now hand you over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
MERCK Kommanditgesellschaft auf Aktien - Head of IR

Thank you very much, Diana, and a very warm welcome to this Q4 and Full Year 2020 Earnings Call. My name is Constantin Fest. I'm Head of Investor Relations here at Merck. Please note that presenting today are Stefan Oschmann, our group CEO; and Marcus Kuhnert, our Group CFO; as well as Kai Beckmann, CEO of our Electronics Business Sector previously PM. For a short introduction to the capital markets, Peter Guenter, our new CEO of our Healthcare business sector, is also joining this call and will be available for the Q&A. Please note that Danny Bar-Zohar, our Healthcare Global Head of Development is also available for questions. Lastly, I'm delighted to let you know that Belen Garijo, Vice Chair of the Executive Board and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot